GVHD
Of 225 patients receiving allogeneic transplants, 50 (22.2%) developed severe GVHD (median days to diagnosis 74 (IQR 37-208)) (Table 3). Neither pre-HSCT nor day 0-30 GV were associated with time-to-GVHD in multivariable analysis.